Aegerion CEO on Cholesterol Drug Lomitapide

Aegerion CEO on Cholesterol Drug Lomitapide Play

Oct. 18 (Bloomberg) -- Marc Beer, chief executive officer of Aegerion Pharmaceuticals Inc., talks about the company's lomitapide drug to treat the most life-threatening forms of high cholesterol. A U.S. Food and Drug Administration panel supported the use of the drug. Beer speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)

  • On Air Now

    Taking Stock with Pimm Fox Watch Now

  • Next

    Bloomberg West

blog comments powered by Disqus